• Home
  •  / New Orleans BioInnovation Center

New Orleans BioInnovation Center

    OverviewSuggest Edit

    The New Orleans BioInnovation Center is a not-for-profit technology business incubator focused on the development of bioscience innovation. It provides biotechnology-related companies with access to customized commercialization services, facilities, and a support network of entrepreneurs, researchers, business, and community leaders. The Company operates New Orleans BioFund which supports small businesses and provides startup investment options such as equity, convertible debt, and loan financing.

    TypePrivate
    Founded2002
    HQNew Orleans, LA, USMap
    Websiteneworleansbio.com

    Recent NewsAll News

    Latest Updates

    Employees (est.) (Jan 2021)19(-5%)
    Cybersecurity ratingAMore

    Key People/Management at New Orleans BioInnovation Center

    Kris Khalil

    Kris Khalil

    Interim President & BioFund Managing Director
    Robin Forman

    Robin Forman

    Director
    Joseph M. Moerschbaecher

    Joseph M. Moerschbaecher

    Director
    Patrick Norton

    Patrick Norton

    Chair
    Steve Nelson

    Steve Nelson

    Vice-Chair
    Andre Rubenstein

    Andre Rubenstein

    Secretary/Treasurer
    Show more

    New Orleans BioInnovation Center Office Locations

    New Orleans BioInnovation Center has an office in New Orleans
    New Orleans, LA, US (HQ)
    1441 Canal St
    Show all (1)

    New Orleans BioInnovation Center Financials and Metrics

    Summary Metrics

    Founding Date

    		2002

    New Orleans BioInnovation Center Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    93/100

    Learn more about our premium products
    SecurityScorecard logo

    New Orleans BioInnovation Center Online and Social Media Presence

    New Orleans BioInnovation Center's Trends

    Embed Graph

    New Orleans BioInnovation Center Blogs

    January 11, 2021

    BioAesthetics Doubles Initial $2.5M Funding Target & Welcomes New Director

    BioAesthetics Announces Close of Series A, Doubles Initial $2.5M Target and Welcomes New Director   RESEARCH TRIANGLE PARK, NC. (Jan. 11, 2021) — BioAesthetics Corporation today announced that it has doubled its initial Series A funding goal of $2.5 million, closed on Dec. 30, 2020, at $5 million to…
    December 18, 2020

    Obatala Receives Ochsner Health Funding

    Obatala Sciences, Receives Investment from Healthcare Innovation Fund II This update is based on an article by Anthony Mcauley, published yesterday on nola.com:  Obatala Sciences, a NOBIC client company that helps pharmaceutical companies bring new drugs to market faster than through conventional te…
    December 04, 2020

    BioFund Portfolio Company, BIoAesthetics, Lands University Clinical Study

    BioAesthetics Announces University Clinical Study for its Nipple Reconstruction Graft NACgraft Aims to Improve Quality-of-Life for Breast Cancer Patients   RESEARCH TRIANGLE PARK, NC. (Dec. 3, 2020) —  BioAesthetics Corporation yesterday announced a clinical study of its nipple reconstruction graft …
    November 16, 2020

    NOBIC Client Chosen Diagnostics’ Device Authorized as Breakthrough

    Chosen Diagnostics’ NECDetect for Preterm Babies Authorized as Breakthrough Device by FDA NEW ORLEANS, LA. (Nov. 16, 2020) — Chosen Diagnostics is pleased to announce that the US Food & Drug Administration (FDA) has granted its NECDetect, and its proposed indication for use, the designation of a…
    November 05, 2020

    AxoSim Receives Investment from Benson Capital Partners

    Benson Capital Partners Announces First Investment in AxoSim, Inc. AxoSim, Inc, Provider of BrainSim™ & NerveSim™ Neurological Drug Discovery Platforms, and BioFund Portfolio Company, Teams with Benson Capital Partners & Jefferson Capital Partners Benson Capital Partners announces its first …
    October 01, 2020

    News: BioFund Portfolio Company BioAesthetics Raises $2.5 million

    News: BioFund Portfolio Company BioAesthetics surpasses $2.5 million target raise BioAesthetics Surpasses Series A Goal, Further Advancing the Nipple-Areolar Complex Graft to Clinical Use BioAesthetics Corporation today announced that it has significantly surpassed its Series A funding goal of $2.5 …
    Show more

     New Orleans BioInnovation Center Frequently Asked Questions

    • When was New Orleans BioInnovation Center founded?

      New Orleans BioInnovation Center was founded in 2002.

    • Who are New Orleans BioInnovation Center key executives?

      New Orleans BioInnovation Center's key executives are Kris Khalil, Robin Forman and Joseph M. Moerschbaecher.

    • How many employees does New Orleans BioInnovation Center have?

      New Orleans BioInnovation Center has 19 employees.

    • Who are New Orleans BioInnovation Center competitors?

      Competitors of New Orleans BioInnovation Center include 32 Advisors, Imperial Innovations and Paragon Biosciences.

    • Where is New Orleans BioInnovation Center headquarters?

      New Orleans BioInnovation Center headquarters is located at 1441 Canal St, New Orleans.

    • Where are New Orleans BioInnovation Center offices?

      New Orleans BioInnovation Center has an office in New Orleans.

    • How many offices does New Orleans BioInnovation Center have?

      New Orleans BioInnovation Center has 1 office.